ATE359816T1 - Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren - Google Patents

Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren

Info

Publication number: ATE359816T1
Authority: AT; Austria
Prior art keywords: animals; preventing; flavivirus infections; treating flavivirus; treating
Prior art date: 2001-10-19

Application number

AT02806687T

Other languages

English (en)

Inventor

Thomas P Monath

Juan Arroyo

Original Assignee

Acambis Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-19

Filing date

2002-10-21

Publication date

2007-05-15

2002-10-21 Application filed by Acambis Inc filed Critical Acambis Inc

2007-05-15 Application granted granted Critical

2007-05-15 Publication of ATE359816T1 publication Critical patent/ATE359816T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT02806687T 2001-10-19 2002-10-21 Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren ATE359816T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US34684501P	2001-10-19	2001-10-19

Publications (1)

Publication Number	Publication Date
ATE359816T1 true ATE359816T1 (de)	2007-05-15

Family

ID=27662959

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02806687T ATE359816T1 (de)	2001-10-19	2002-10-21	Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren

Country Status (20)

Country	Link
US (1)	US6878372B2 (de)
EP (1)	EP1441761B1 (de)
JP (2)	JP5164305B2 (de)
KR (3)	KR20120016315A (de)
AT (1)	ATE359816T1 (de)
AU (1)	AU2002365922B2 (de)
BR (1)	BR0213408A (de)
CA (1)	CA2464138C (de)
CY (1)	CY1107439T1 (de)
DE (1)	DE60219658T2 (de)
DK (1)	DK1441761T3 (de)
ES (1)	ES2284984T3 (de)
IL (2)	IL161501A0 (de)
MX (1)	MXPA04003692A (de)
NZ (1)	NZ532385A (de)
PT (1)	PT1441761E (de)
RU (1)	RU2313367C2 (de)
SI (1)	SI1441761T1 (de)
WO (1)	WO2003063725A2 (de)
ZA (1)	ZA200403047B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6962708B1 (en) *	1997-02-28	2005-11-08	Acambis, Inc.	Chimeric flavivirus vaccines
US20030148261A1 (en) *	2001-03-12	2003-08-07	Erol Fikrig	Compositions and methods comprising West Nile virus polypeptides
EP1401859B1 (de) *	2001-06-01	2013-08-07	Sanofi Pasteur Biologics Co.	Chimere flavivirus-vektoren
US20050002968A1 (en) *	2002-01-15	2005-01-06	Monath Thomas P.	Flavivirus vaccines
JP2005519639A (ja)	2002-01-15	2005-07-07	アカンビスインコーポレーティッド	フラビウイルスワクチン
KR101150584B1 (ko) *	2002-11-15	2012-06-27	사노피 파스테르 바이오로직스 씨오	웨스트 나일 바이러스 백신
EP1896069B1 (de) *	2005-06-24	2013-03-13	Intervet International BV	Inaktivierte chimäre impfstoffe und entsprechende verwendungsverfahren
WO2007015783A2 (en) *	2005-07-22	2007-02-08	Research Development Foundation	Attenuated strains of flaviviruses , and uses thereof
SG193821A1 (en)	2008-08-29	2013-10-30	Boehringer Ingelheim Vetmed	West nile virus vaccine
WO2010085358A2 (en) *	2009-01-23	2010-07-29	The Board Of Regents Of The University Of Texas System	Flaviviruses expressing the prm, e, and ns1 proteins of other flaviviruses and uses thereof
AU2012229192B2 (en)	2011-03-14	2017-04-20	Boehringer Ingelheim Animal Health USA Inc.	Equine Rhinitis vaccine
KR101868554B1 (ko)	2016-10-18	2018-06-19	강원대학교산학협력단	브루셀라 어보투스 ba15 변이주 및 이를 포함하는 브루셀라병 예방용 백신 조성물
GB201716222D0 (en) *	2017-10-05	2017-11-22	Univ Leuven Kath	Chimeric Flavivirus Vaccines
CN113583117B (zh) *	2018-04-04	2022-04-15	中国科学院微生物研究所	一种高灵敏度的黄热病毒人源单克隆抗体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6184024B1 (en) *	1988-07-14	2001-02-06	The United States Of America As Represented By The Department Of Health And Human Services	Chimeric and/or growth-restricted flaviviruses
EP0872553B1 (de) *	1991-09-19	2000-11-15	THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary of the Department of HEALTH AND HUMAN SERVICES	Chimäre und/oder wachstumgehemmte Flaviviren
ES2345614T3 (es)	1997-02-28	2010-09-28	Sanofi Pasteur Biologics Co.	Vacunas quimericas de flavivirus.
AU1813901A (en)	1999-12-01	2001-06-12	Oravax, Inc	Chimeric flavivirus vaccines

2002
- 2002-10-21 KR KR1020127000689A patent/KR20120016315A/ko not_active Withdrawn
- 2002-10-21 NZ NZ532385A patent/NZ532385A/en not_active IP Right Cessation
- 2002-10-21 RU RU2004115107/15A patent/RU2313367C2/ru not_active IP Right Cessation
- 2002-10-21 DE DE60219658T patent/DE60219658T2/de not_active Expired - Lifetime
- 2002-10-21 MX MXPA04003692A patent/MXPA04003692A/es active IP Right Grant
- 2002-10-21 EP EP02806687A patent/EP1441761B1/de not_active Expired - Lifetime
- 2002-10-21 JP JP2003563423A patent/JP5164305B2/ja not_active Expired - Fee Related
- 2002-10-21 AU AU2002365922A patent/AU2002365922B2/en not_active Ceased
- 2002-10-21 IL IL16150102A patent/IL161501A0/xx unknown
- 2002-10-21 ES ES02806687T patent/ES2284984T3/es not_active Expired - Lifetime
- 2002-10-21 KR KR10-2004-7005766A patent/KR20040052245A/ko not_active Ceased
- 2002-10-21 PT PT02806687T patent/PT1441761E/pt unknown
- 2002-10-21 AT AT02806687T patent/ATE359816T1/de active
- 2002-10-21 CA CA2464138A patent/CA2464138C/en not_active Expired - Lifetime
- 2002-10-21 BR BR0213408-0A patent/BR0213408A/pt not_active Application Discontinuation
- 2002-10-21 WO PCT/US2002/033795 patent/WO2003063725A2/en not_active Ceased
- 2002-10-21 US US10/277,478 patent/US6878372B2/en not_active Expired - Lifetime
- 2002-10-21 KR KR1020107014594A patent/KR101131579B1/ko not_active Expired - Fee Related
- 2002-10-21 SI SI200230548T patent/SI1441761T1/sl unknown
- 2002-10-21 DK DK02806687T patent/DK1441761T3/da active
2004
- 2004-04-19 IL IL161501A patent/IL161501A/en not_active IP Right Cessation
- 2004-04-21 ZA ZA2004/03047A patent/ZA200403047B/en unknown
2007
- 2007-06-21 CY CY20071100824T patent/CY1107439T1/el unknown
2010
- 2010-05-31 JP JP2010123708A patent/JP2010215647A/ja active Pending

Also Published As

Publication number	Publication date
EP1441761A2 (de)	2004-08-04
DE60219658D1 (de)	2007-05-31
DE60219658T2 (de)	2008-01-03
RU2004115107A (ru)	2005-04-20
BR0213408A (pt)	2004-11-03
CY1107439T1 (el)	2012-12-19
AU2002365922B2 (en)	2007-11-22
JP2005516974A (ja)	2005-06-09
US6878372B2 (en)	2005-04-12
JP2010215647A (ja)	2010-09-30
ES2284984T3 (es)	2007-11-16
RU2313367C2 (ru)	2007-12-27
KR20120016315A (ko)	2012-02-23
US20030129201A1 (en)	2003-07-10
KR20100092038A (ko)	2010-08-19
NZ532385A (en)	2007-01-26
IL161501A (en)	2010-05-17
KR20040052245A (ko)	2004-06-22
SI1441761T1 (sl)	2007-08-31
KR101131579B1 (ko)	2012-03-30
CA2464138A1 (en)	2003-08-07
PT1441761E (pt)	2007-07-16
MXPA04003692A (es)	2005-04-08
ZA200403047B (en)	2005-06-29
WO2003063725A3 (en)	2003-10-30
JP5164305B2 (ja)	2013-03-21
EP1441761B1 (de)	2007-04-18
CA2464138C (en)	2013-08-13
IL161501A0 (en)	2004-09-27
DK1441761T3 (da)	2007-08-27
WO2003063725A2 (en)	2003-08-07
EP1441761A4 (de)	2004-12-29

Legal Events

Date

Code

Title

Description

2007-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1441761

Country of ref document: EP

Publication	Publication Date	Title
DE60227095D1 (de)	2008-07-24	Zusammensetzungen und verfahren zur behandlung von abgebundenem gips
ATE448775T1 (de)	2009-12-15	Rifalazil zur behandlung von infektionen mit clostridium difficile
EP1701664A4 (de)	2010-11-24	System und verfahren zur behandlung von gewebe
DE60231601D1 (de)	2009-04-30	Einrichtung und verfahren zur behandlung
EP1469871A4 (de)	2006-08-23	Verfahren zur behandlung von apoptose und zusammensetzungen dafür
DE60120667D1 (de)	2006-07-27	Methoden und mittel zur behandlung von bandscheibenverschleiss
EP1438054A4 (de)	2006-07-26	Verfahren und zusammensetzungen zur behandlung von flaviviren und pestiviren mit 4'-modifiziertem nucleosid
EP1324780A4 (de)	2005-06-22	Methoden zur behandlung von herzarrhythmie
EP1626730A4 (de)	2006-10-18	Verfahren, gerät und zusammensetzung zur behandlung von akne
ATE313328T1 (de)	2006-01-15	Verfahren zur behandlung von mittelohrinfektionen
DE60034871D1 (de)	2007-06-28	Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
CY1107439T1 (el)	2012-12-19	Μεθοδοι προληψης και θεραπειας μολυνσης απο ιο του γενους flavivirus σε ζωα
EP1635801A4 (de)	2008-01-23	Verfahren zur behandlung und prävention von herzarrhythmie
DE60139783D1 (de)	2009-10-15	Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
ATE415163T1 (de)	2008-12-15	Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
EP1506001A4 (de)	2005-05-18	Verfahren und zusammensetzungen zur behandlung von epithelläsionen in vagina, zervix und uterus
EP1468005A4 (de)	2006-05-03	Verfahren zur verwendung von konjugaten von sacchariden und acetamidino- oder guanidinoverbindungen zur behandlung von bakteriellen infektionen
ATE463246T1 (de)	2010-04-15	Formulierung und verfahren zur behandlung von thrombocythämie
DE60211913D1 (de)	2006-07-06	Aryl- (oder heteroaryl-) azolylcarbynolderivatve zur behandlung von harninkontinenz
DE50213931D1 (de)	2009-11-26	Verfahren und vorrichtung zur behandlung von fehlerverdacht
ATE347888T1 (de)	2007-01-15	Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
ATE283920T1 (de)	2004-12-15	Verfahren zur immunisierung und behandlung von h. pylori infektion
DE60142786D1 (de)	2010-09-23	Zusammensetzungen und methoden zur behandlung von candidosen
DE60103939D1 (de)	2004-07-29	Gehärteter Kautschuk und Verfahren zur Behandlung von gehärtetem Kautschuk
DE60144493D1 (de)	2011-06-01	Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen